|
Collection group |
Samples |
IgG‐positive |
IgG titre = 10 |
IgG titre ≥ 160 |
IgA or IgM positive* |
Neutralising antibodies* |
|---|---|---|---|---|---|---|
|
General pathology |
3231 |
19 [0.6%] |
11 (58%) |
3 (16%) |
6 (32%) |
8 (42%) |
|
Antenatal screening |
560 |
7 [1%] |
3 (43%) |
0 |
0 |
5 (71%) |
|
Plasmapheresis donors |
1548 |
12 [0.8%] |
2 (17%) |
1 (8%) |
0 |
11 (92%) |
*
Only samples positive for SARS‐CoV‐2‐specific IgG were tested for SARS‐CoV‐2‐specific IgA, IgM, and neutralising antibody.